• LinkedIn
  • Mail
About Medifactia ABLocation
Medifactia HR
  • Healthcare Professionals
    • Overview
      • Validated Method
      • Origin & Development
    • Guidelines & Standards
    • Radiopaque Markers
      • Ingredients
    • Clinical Guidance
      • Reading the results
      • Application
    • Clinical Evidence
  • Patients & Caregivers
    • Colon Transit Study
      • Gastrointestinal Disorders
    • Colon Transit Markers
    • Instructions
  • CTT ReportingSystem
  • Pediatrics
  • CTT Login
  • Order now
  • Menu

Zdravstveni stručnjaci

Ponosni smo što nudimo najmodernije radiopaknim markerima Transit-Pellets koji su dizajnirani za poboljšanje procjene i liječenja poremećaja pokretljivosti poput zatvora, proljeva i sindroma iritabilnog crijeva (IBS). Naši markeri proizvode se prema Transit-Pellets method. Osim toga, pružamo online standardizirani izvještaj o tranzitu kolona koji je namijenjen liječnicima i radiolozima koji provode terapiju.

Learn more
International experts (Mayo, Gothenburg and others) states that there are two transit methods able to differ between subtypes of functional disorders of the lower gastrointestinal tract and healthy individuals, the Mayo and the Transit-Pellets principle, the latter a study on 359 patients. The authors emphasize that both methods are validated and with respect to radiopaque markers a method with marker ingestion over six days should be preferred.
Keller et al., 2020
Slight differences in performing the test exist between laboratories, with one validated method being the ingestion of 10 radiopaque markers per day for six consecutive days, followed by fluoroscopy imaging on the morning of day 7 to count the remaining markers.
Aziz et al., 2020
The CTT of normal healthy children is not sex- or age-related (above the age of 3 years). The Abrahamson method for CTT measurement by using bony landmarks for the determination of colon segments is easy to perform and well tolerated with a virtual inexistent rating difference between different observers
Velde et al., 2013
Investigations of anorectal manometry, endosonography and colonic transit studies provide noninvasive objective assessment of diagnosis and severity of chronic IC and fecal incontinence in children. This information is valuable for the clinician to plan the treatment strategy and for parents and children to understand the underlying pathophysiology.
Keshtgar et al., 2013
CTT provides an objective measure to assess childhood constipation. To date, 6 studies using 5 different methods have been published reporting values for healthy children. Comparing these, Abrahamson’s method has low radiation exposure and is well tolerated. This study contributes additional normal values in children.
Wagener et al., 2004
PreviousNext

International experts (Mayo, Gothenburg and others) states that there are two transit methods able to differ between subtypes of functional disorders of the lower gastrointestinal tract and healthy individuals, the Mayo and the Transit-Pellets principle, the latter a study on 359 patients. The authors emphasize that both methods are validated and with respect to radiopaque markers a method with marker ingestion over six days should be preferred.

Keller et al., 2020

Slight differences in performing the test exist between laboratories, with one validated method being the ingestion of 10 radiopaque markers per day for six consecutive days, followed by fluoroscopy imaging on the morning of day 7 to count the remaining markers.

Aziz et al., 2020

The CTT of normal healthy children is not sex- or age-related (above the age of 3 years). The Abrahamson method for CTT measurement by using bony landmarks for the determination of colon segments is easy to perform and well tolerated with a virtual inexistent rating difference between different observers

Velde et al., 2013

Investigations of anorectal manometry, endosonography and colonic transit studies provide noninvasive objective assessment of diagnosis and severity of chronic IC and fecal incontinence in children. This information is valuable for the clinician to plan the treatment strategy and for parents and children to understand the underlying pathophysiology.

Keshtgar et al., 2013

CTT provides an objective measure to assess childhood constipation. To date, 6 studies using 5 different methods have been published reporting values for healthy children. Comparing these, Abrahamson’s method has low radiation exposure and is well tolerated. This study contributes additional normal values in children.

Wagener et al., 2004

Ispitivanje prolaza sadržaja kroz debelo crijevo markerima Transit-Pellets često se koristi u pacijenata koji pate od kronične konstipacije, kroničnog proljeva i/ili sindroma iritabilnog crijeva (IBS). Svrha ovog testa je procijeniti vrijeme prolaza i koliko brzo ili sporo hrana/stolica putuje kroz crijeva. Test podrazumijeva oralno uzimanje sedam kapsula od kojih svaka sadrži malene markere koji se mogu vizualizirati pomoću rendgenske slike, tijekom razdoblja od šest dana. Gutanje markera je sigurno i markeri će se eliminirati izmetom te ih se može sigurno puštanjem vode.

  • FDA 510(k) odobrenje za upotrebu u odraslih pacijenata
  • FDA 510(k) odobrenje za upotrebu u pedijatrijskih bolesnika (≥2 g/o)
  • S oznakom CE (za primjenu u odraslih pacijenata)
  • Kapsulirani markeri prolaza kroz debelo crijevo
  • Vegetarijanske kapsule
  • Lako za primjenu
  • Proizvedeno u Švedskoj
Learn more

Potvrđena metoda i markeri sigurnog prolaza kroz debelo crijevo za kvantitativnu procjenu ukupnog i regionalnog prolaza kroz debelo crijevo

Transit-Pellets method i Transit-Pellets radionepropušni markeri (radiopaque markers) mogu se koristiti za:

  • Mjerenje brzog, normalnog i sporog crijevnog prolaza
  • Razlikovanje konstipacije sporog od konstipacije normalnog prolaza
  • Identificiranje segmentalne disfunkcije debelog crijeva u bolesnika s konstipacijom
  • Razlikovanje normalnog od brzog proljeva
  • Identificiranje učinaka liječenja u bolesnika s kroničnom konstipacijom

Test prolaza kroz debelo crijevo Transit-Pellets method, nekada poznate kao Abrahamsson method, te radiopaknim markerima Transit-Pellets može kvantificirati ozbiljnost problema s prolazom. Test može biti važan u određivanju potrebe za u odabiru odgovarajuće terapije i davanju dugoročne prognoze. Rezultati testa mogu poslužiti kao smjernice za donošenje odluka u ovim područjima.

Reference možete pronaći u odjeljku VALIDATED METHOD.

Ilustracija kretanja markera Transit-Pellets

Dobijte točne rezultate pomoću sustava Transit-Pellets CTT Reporting System:
standardizirani online nalaz testa prolaza kroz debelo crijevo za liječnike i radiologe

Mi u Medifactia razumijemo važnost točnih i pouzdanih rezultata testova u medicini. Zato smo izradili standardizirani online nalaz testa prolaza kroz debelo crijevo osobito za liječnike koji liječe pacijente i radiologe. S ovim izvješćem dobit ćete pristup preciznim i potpunim profilima tranzita kolona za svakog pacijenta, što može pružiti smjer za dodatne istrage ili strategije liječenja.

S pacijentovom rendgenskom pločom u ruci, prebrojite preostale markere i unesite brojeve kako vas vodi CTT Reporting System. Sustav će zatim proizvesti sveobuhvatan nalaz, koji sadržava:

  • ilustraciju debelog crijeva s odgovarajućim brojem markera u svakom od četiri segmenta debelog crijeva
  • tablicu koja prikazuje informacije o ukupnom vremenu prolaza kroz debelo crijevo pacijenta, u usporedbi s utvrđenim referentnim vrijednostima
  • grafički prikaz pacijentova segmentalnog vremena prolaska, u usporedbi s utvrđenim referentnim vrijednostima
  • smjernice o tome kako koristiti pacijentove rezultate za prilagodbu plana liječenja ili savjete o dodatnim vrstama testiranja

Ovaj najsuvremeniji nalaz testa prolaza kroz debelo crijevo koji proizvodi CTT Reporting System namijenjen je uključivanju i informiranju pacijenata te kompleksne informacije predstavlja na lako razumljiv način koji će ih oduševiti.

Learn more
See how
Login

Questions?

Contact Us. We’re here to help!

Diana Nyström
+46 (0) 8-460 072 06
diana.nystrom@medifactia.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.

Medifactia AB

Address:
c/o IOFFICE Business Center
Kungsgatan 60
111 22 Stockholm

Phone: +46 (0) 8-460 072 06
E-mail: info@medifactia.com

Business hours Monday to Friday from 8:00am to 5:00pm

Read more

About Medifactia AB
Terms of Use
Privacy Statement

Tools

CTT Reporting System
Downloads

DIstributors

Medifactia Toolbox
The information on this website is for your general information only. Information you read on this website cannot replace the relationship that you have with your health care professional and is not intended to affect that relationship in any way. Medifactia does not practice medicine or provide medical services or advice, and the information on this website should not be considered medical advice. You should always talk to your health care professional for diagnosis and treatment. Health information changes quickly. Therefore, it is always best to confirm information with your health care professional.

Powered by Panzify
Scroll to top

Clinical Decision Support Tool – Irritable Bowel Syndrome1

1. https://svenskgastroenterologi.se. The Clinical Decision Algorithm has undergone minor adjustments compared to the original version.

Pacijent & Skrbnik

Svaki pacijent je jedinstven.
Razumijte svoje gastrointestinalne probleme s MOTILITETOM.

Čitaj više